Clinical significance of the parental origin of the X chromosome in Turner syndrome

被引:68
作者
Sagi, Liora
Zuckerman-Levin, Nehama
Gawlik, Aneta
Ghizzoni, Lucia
Buyukgebiz, Atilla
Rakover, Yardena
Bistritzer, Tzvi
Admoni, Osnat
Vottero, Alessandra
Baruch, Oshrat
Fares, Fuad
Malecka-Tendera, Ewa
Hochberg, Ze'ev [1 ]
机构
[1] Meyer Childrens Hosp, Div Endocrinol, IL-31096 Haifa, Israel
[2] Silesian Univ, Sch Med, Dept Pediat Endocrinol & Diabet, PL-40287 Katowice, Poland
[3] Parma Univ, I-143100 Parma, Italy
[4] Ismir Univ, Dept Pediat, TR-35360 Ismir, Turkey
[5] Haemek Hosp, IL-18101 Afula, Israel
[6] Asaf Harofeh Hosp, Dept Pediat, Zerifin, Israel
[7] Carmel Hosp, Dept Biochem & Mol Genet, Haifa, Israel
[8] Technion Israel Inst Technol, Fac Med, IL-31096 Haifa, Israel
关键词
D O I
10.1210/jc.2006-0158
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: The phenotype in Turner syndrome (TS) is variable, even in patients with a supposedly nonmosaic karyotype. Previous work suggested that there were X-linked parent-of-origin effects on the phenotype. Hypothesis: The TS phenotype is influenced by the parental origin of the missed X chromosome. Design: This was a multicenter prospective study of TS patients and both their parents, determining parental origin of the X-chromosome, and characterizing the clinical phenotype. Patients and Methods: Eighty-three TS patients and their parents were studied. Inclusion criteria were TS with karyotype 45, X or 46Xi(Xq). Four highly polymorphic microsatellite markers on the X-chromosome DMD49, DYSII, DXS1283, and the androgen receptor gene and three Y chromosome markers, SRY, DYZ1, and DYZ3. Outcome Measures: The study determined the correlation between the parental origin of the X chromosome and the unique phenotypic traits of TS including congenital malformations, anthropometry and growth pattern, skeletal defects, endocrine traits, education, and vocation. Results: Eighty-three percent of 45, X retained their maternal X (X-m), whereas 64% 46Xi( Xq) retained their paternal X (X-p, P < 0.001). Kidney malformations were exclusively found in Xm patients (P = 0.030). The Xm group had lower total and low-density lipoprotein cholesterol (P < 0.003), and higher body mass index SD score (P = 0.030) that was not maintained after GH treatment. Response to GH therapy was comparable. Ocular abnormalities were more common in the paternal X group (P = 0.017), who also had higher academic achievement. Conclusions: The parental origin of the missing short arm of the X chromosome has an impact on overweight, kidney, eye, and lipids, which suggests a potential effect of an as-yet-undetermined X chromosome gene imprinting.
引用
收藏
页码:846 / 852
页数:7
相关论文
共 27 条
[1]  
CHROUSOS GA, 1984, OPHTHALMOLOGY, V91, P926
[2]   POSSIBLE ROLE OF IMPRINTING IN THE TURNER PHENOTYPE [J].
CHU, CE ;
DONALDSON, MDC ;
KELNAR, CJH ;
SMAIL, PJ ;
GREENE, SA ;
PATERSON, WF ;
CONNOR, JM .
JOURNAL OF MEDICAL GENETICS, 1994, 31 (11) :840-842
[3]   Xlr3b is a new imprinted candidate for X-linked parent-of-origin effects on cognitive function in mice [J].
Davies, W ;
Isles, A ;
Smith, R ;
Karunadasa, D ;
Burrmann, D ;
Humby, T ;
Ojarikre, O ;
Biggin, C ;
Skuse, D ;
Burgoyne, P ;
Wilkinson, L .
NATURE GENETICS, 2005, 37 (06) :625-629
[4]   PREVALENCE OF CARDIOVASCULAR MALFORMATIONS AND ASSOCIATION WITH KARYOTYPES IN TURNERS-SYNDROME [J].
GOTZSCHE, CO ;
KRAGOLSEN, B ;
NIELSEN, J ;
SORENSEN, KE ;
KRISTENSEN, BO .
ARCHIVES OF DISEASE IN CHILDHOOD, 1994, 71 (05) :433-436
[5]   Choosing an oestrogen replacement therapy in young adult women with Turner syndrome [J].
Guttmann, H ;
Weiner, Z ;
Nikolski, E ;
Ish-Shalom, S ;
Itskovitz-Eldor, J ;
Aviram, M ;
Reisner, S ;
Hochberg, Z .
CLINICAL ENDOCRINOLOGY, 2001, 54 (02) :159-164
[6]   Genomic imprinting in Turner syndrome: Effects on response to growth hormone and on risk of sensorineural hearing loss [J].
Hamelin, Catherine E. ;
Anglin, Greg ;
Quigley, Charmian A. ;
Deal, Cheri L. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (08) :3002-3010
[7]  
HASSOLD T, 1992, HUM GENET, V89, P647
[8]   Final height in young women with Turner syndrome after GH therapy: an open controlled study [J].
Hochberg, Z ;
Zadik, Z .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1999, 141 (03) :218-224
[9]  
Ishikawa H, 1999, J REPROD FERTIL, V115, P263, DOI 10.1530/jrf.0.1150263
[10]  
Jacobs P, 1989, Prog Clin Biol Res, V311, P135